FDA Drug Application (021453) for ZERIT XR by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number021453
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage37.5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZERIT XR
Active IngredientSTAVUDINE

Active IngredientCount
List of drugs with Active Ingredient STAVUDINE11


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB